Company intelligence / Profile preview

Boca Pharma

Coral Springs, Florida, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Boca Pharma is a specialty pharmaceutical company that develops, manufactures, and markets generic prescription drugs. The company primarily focuses on niche therapeutic categories such as respiratory, pain management, and nephrology, often targeting products with high barriers to entry. In November 2018, Boca Pharma was acquired by Lannett Company for approximately $127 million to bolster Lannett's portfolio of liquid and semi-solid dosage forms. The company maintains a robust pipeline of Abbreviated New Drug Applications (ANDAs) and continues to operate as a key subsidiary within the generic pharmaceutical industry.

Therapeutic areas: NeurologyNephrologyPulmonologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Boca Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boca Pharma.

Explore the full profile